“Leidos (LDOS) Gains Favor with Wall Street Analysts: Is It Time to Invest?”

Avatar photo

Should You Follow Wall Street’s Advice on Leidos (LDOS)?

Investors frequently rely on Wall Street analysts for buy, sell, or hold recommendations. Changes in these ratings can quickly influence stock prices. But how trustworthy are these recommendations?

First, let’s explore what analysts currently think about Leidos (LDOS).

Leidos has an average brokerage recommendation (ABR) of 1.71, which is on a scale from 1 (Strong Buy) to 5 (Strong Sell). This rating comes from recommendations made by 14 brokerage firms, with the rating of 1.71 indicating a position closer to Strong Buy than Buy. Among these recommendations, nine—or 64.3%—are classified as Strong Buy.

Current Trends in Brokerage Recommendations for LDOS

Broker Rating Breakdown Chart for LDOS

For price targets and forecasts for Leidos, click here>>>

While the ABR indicates buying Leidos, relying solely on this metric might not be wise. Research shows that brokerage recommendations often fail to effectively guide investors towards stocks likely to rise in value.

Why is this the case? Brokerage analysts might favor positive ratings due to their firms’ vested interests in covered stocks. Historically, for every “Strong Sell” suggestion, firms tend to issue about five “Strong Buy” recommendations.

This discrepancy suggests that analysts’ interests may not align with those of individual investors. Thus, using this information as a supplement to your own analysis could yield better results.

Our proprietary stock rating tool, the Zacks Rank, has been externally audited and is a credible indicator of short-term price movements. The Zacks Rank categorizes stocks from #1 (Strong Buy) to #5 (Strong Sell), offering insight that complements the ABR for more informed investment decisions.

Understanding the Difference: ABR vs. Zacks Rank

Both ABR and Zacks Rank operate on a scale from 1 to 5, but they are fundamentally distinct measures.

ABR, calculated solely from brokerage recommendations, can appear in decimal form (like 1.28). Conversely, Zacks Rank employs a quantitative model that reflects earnings estimate revisions and is presented as whole numbers from 1 to 5.

Historically, brokerage analysts tend to be overly optimistic due to pressures from their firms, often giving more favorable ratings than warranted. This bias can mislead investors.

In contrast, Zacks Rank is more objective, driven by real-time earnings estimate revisions. Empirical evidence demonstrates a strong correlation between near-term stock price movements and earnings estimates.

Another key distinction is how current the data is. ABR may not always reflect the latest information, while the Zacks Rank updates promptly with the latest earnings estimates, making it timely for predicting stock prices.

Is LDOS a Smart Investment?

Recent earnings estimate revisions for Leidos show a 0.7% increase in the Zacks Consensus Estimate for this year to $10.03.

This growing confidence among analysts about Leidos’ earnings potential, backed by a consensus of higher EPS estimates, suggests that the stock may rise in value soon.

The Zacks Rank for Leidos stands at #2 (Buy) due to the significant change in consensus estimates along with three other favorable factors related to earnings.

In summary, while the ABR suggests a Buy for Leidos, it’s beneficial for investors to consider it as part of a broader analytical framework.

Five Stocks Set to Soar

Each of these stocks has been selected by a Zacks expert as having the potential to double in value in 2024. While past performance isn’t a guarantee, previous recommendations have seen increases of +143.0%, +175.9%, +498.3%, and +673.0%.

Many of these stocks are not well-known yet, providing an exceptional opportunity for investors to jump in early.

Discover These 5 Potential High Performers Now>>

Get the latest recommendations from Zacks Investment Research. Download our report on the 7 Best Stocks for the Next 30 Days for free.

Leidos Holdings, Inc. (LDOS): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.

The free Daily Market Overview 250k traders and investors are reading

Read Now